
India · Medical devices startup
Janitri Innovations Private Limited, based in Bengaluru, Karnataka, is a MedTech and HealthTech startup founded in 2016.
Funding reportedLast round: Seed
Follow Janitri and see its new rounds in your feed.Start following
Janitri Innovations Private Limited, based in Bengaluru, Karnataka, is a MedTech and HealthTech startup founded in 2016.
The company is dedicated to preventing maternal and newborn deaths due to avoidable causes during pregnancy, labor, and postpartum. Janitri specializes in developing affordable and user-friendly medical devices and software for continuous monitoring of fetal, maternal, and newborn health, addressing high mortality rates, especially in developing countries. Janitri offers a range of services, including continuous remote monitoring solutions, AI-driven diagnostic tools, and hospital referral management software. Their flagship products include the KEYAR Fetal Monitoring Patch, DAKSH Smart Obstetric Shock Index Monitor, and a portable Smart Newborn Jaundice Monitor, among others. With 19 patents and a commitment to innovation, Janitri has deployed its solutions in public and private hospitals across India and is focused on improving healthcare access for expectant mothers, particularly in underserved regions.
Funding, as reported
From Janitri's own website: 1 founder, 1 on the team.
What they build
Known for
health carematernal health in lmicsregulatory approved devicesremote monitoringobstetric care solutionsai-based pregnancy analysisdigital healthmaternal health digital toolsconsumershealthcare analyticsfetal wellbeing assessmenthome monitoring solutionshandheld fetal dopplerfetal heart rate monitorneonatal health tech in lmicsnewborn health solutions
Built with from their website
Google MapsGoogle Tag ManagerAmazon CloudFrontCanvaInfluenceMicrosoft PowerPointClarity SDMFont AwesomeMeta Audience NetworkYouTube
Google WorkspaceCloudFlareMax Mega MenuViewport MetaGoogle PlayElement UISWIFTwebpack
Add your raise, your deck and your story, and put Janitri in front of investors. Or tell us what we have wrong.